Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Cox

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
JAMA Oncology|March 3, 2022
Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting: A Multicenter Phase 3 Randomized Clinical TrialXavier Pivot, M A Georgievich, Volodymyr Shamrai, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
The New England Journal of Medicine|March 19, 2010
Performance of common genetic variants in breast-cancer risk modelsSholom Wacholder, Patricia Hartge, Ross Prentice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyHervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Bulletin Du Cancer|July 31, 2016
[Breast cancer screening: On our way to the future]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Bulletin Du Cancer|December 29, 2016
[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Nature Genetics|May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerDavid J Hunter, Peter Kraft, Kevin B Jacobs, et al.
Nature Genetics|July 28, 2015
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteThomas G P Grünewald, Virginie Bernard, Pascale Gilardi-Hebenstreit, et al.
BMC Cancer|July 31, 2009
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Federico Canzian, Rudolf Kaaks, David G Cox, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
JAMA Oncology|March 3, 2022
Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant Setting: A Multicenter Phase 3 Randomized Clinical TrialXavier Pivot, M A Georgievich, Volodymyr Shamrai, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
The New England Journal of Medicine|March 19, 2010
Performance of common genetic variants in breast-cancer risk modelsSholom Wacholder, Patricia Hartge, Ross Prentice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyHervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Bulletin Du Cancer|July 31, 2016
[Breast cancer screening: On our way to the future]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Bulletin Du Cancer|December 29, 2016
[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]]Suzette Delaloge, Thomas Bachelot, François-Clément Bidard, et al.
Nature Genetics|May 29, 2007
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerDavid J Hunter, Peter Kraft, Kevin B Jacobs, et al.
Nature Genetics|July 28, 2015
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteThomas G P Grünewald, Virginie Bernard, Pascale Gilardi-Hebenstreit, et al.
BMC Cancer|July 31, 2009
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)Federico Canzian, Rudolf Kaaks, David G Cox, et al.
Pageof 11